{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:56Z","timestamp":1792782776168,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200802"],"award-info":[{"award-number":["82200802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270760"],"award-info":[{"award-number":["82270760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Technology Enhancement Project between the Second Affiliated Hospital of Nanjing Medical University and Binhai County People's Hospital","award":["EFYBH01C"],"award-info":[{"award-number":["EFYBH01C"]}],"id":[{"id":"https:\/\/ror.org\/04pge2a40","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Jiangsu province","award":["BK20201497"],"award-info":[{"award-number":["BK20201497"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00125-025-06519-y","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T03:34:20Z","timestamp":1755315260000},"page":"2879-2898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["BCKDK accelerates the progression of diabetic kidney disease by regulating leucine-mediated metabolic remodelling in renal tubular cells"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2797-8872","authenticated-orcid":false,"given":"Caifeng","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemeng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-4502","authenticated-orcid":false,"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-2974","authenticated-orcid":false,"given":"Ke","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-2469","authenticated-orcid":false,"given":"Chunsun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0453-4598","authenticated-orcid":false,"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"4 Suppl 1","key":"6519_CR1","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","volume":"77","author":"KL Johansen","year":"2021","unstructured":"Johansen KL, Chertow GM, Foley RN et al (2021) US renal data system 2020 annual data report: epidemiology of kidney disease in the united states. Am J Kidney Dis 77(4 Suppl 1):A7\u2013A8. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.002","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"6519_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41588-022-01097-w","volume":"54","author":"H Liu","year":"2022","unstructured":"Liu H, Doke T, Guo D et al (2022) Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nat Genet 54(7):950\u2013962. https:\/\/doi.org\/10.1038\/s41588-022-01097-w","journal-title":"Nat Genet"},{"issue":"6","key":"6519_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","volume":"16","author":"V Vallon","year":"2020","unstructured":"Vallon V, Thomson SC (2020) The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol 16(6):317\u2013336. https:\/\/doi.org\/10.1038\/s41581-020-0256-y","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"6519_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41467-021-21301-5","volume":"12","author":"Z Tian","year":"2021","unstructured":"Tian Z, Liang M (2021) Renal metabolism and hypertension. Nat Commun 12(1):963. https:\/\/doi.org\/10.1038\/s41467-021-21301-5","journal-title":"Nat Commun"},{"issue":"10","key":"6519_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","volume":"32","author":"T Doke","year":"2022","unstructured":"Doke T, Susztak K (2022) The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development. Trends Cell Biol 32(10):841\u2013853. https:\/\/doi.org\/10.1016\/j.tcb.2022.03.012","journal-title":"Trends Cell Biol"},{"issue":"4","key":"6519_CR6","doi-asserted-by":"publisher","first-page":"e165654","DOI":"10.1172\/JCI165654","volume":"133","author":"S Mohandes","year":"2023","unstructured":"Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K (2023) Molecular pathways that drive diabetic kidney disease. J Clin Invest 133(4):e165654. https:\/\/doi.org\/10.1172\/JCI165654","journal-title":"J Clin Invest"},{"issue":"9","key":"6519_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00592-023-02094-z","volume":"60","author":"C Shi","year":"2023","unstructured":"Shi C, Wan Y, He A et al (2023) Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication. Acta Diabetol 60(9):1199\u20131207. https:\/\/doi.org\/10.1007\/s00592-023-02094-z","journal-title":"Acta Diabetol"},{"issue":"2","key":"6519_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast MD, Jang C, Hui S et al (2019) Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab 29(2):417-429 e414. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.013","journal-title":"Cell Metab"},{"issue":"1","key":"6519_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00125-021-05584-3","volume":"65","author":"S Mutter","year":"2022","unstructured":"Mutter S, Valo E, Aittomaki V et al (2022) Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes. Diabetologia 65(1):140\u2013149. https:\/\/doi.org\/10.1007\/s00125-021-05584-3","journal-title":"Diabetologia"},{"issue":"5","key":"6519_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas MA, Sirich TL, Mathew AV et al (2014) Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int 85(5):1214\u20131224. https:\/\/doi.org\/10.1038\/ki.2013.497","journal-title":"Kidney Int"},{"issue":"3","key":"6519_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2337\/dc12-0895","volume":"36","author":"P Wurtz","year":"2013","unstructured":"Wurtz P, Soininen P, Kangas AJ et al (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36(3):648\u2013655. https:\/\/doi.org\/10.2337\/dc12-0895","journal-title":"Diabetes Care"},{"issue":"4","key":"6519_CR12","doi-asserted-by":"publisher","first-page":"e1827","DOI":"10.1210\/clinem\/dgaa751","volume":"106","author":"F Vanweert","year":"2021","unstructured":"Vanweert F, de Ligt M, Hoeks J, Hesselink MKC, Schrauwen P, Phielix E (2021) Elevated plasma branched-chain amino acid levels correlate with type 2 diabetes-related metabolic disturbances. J Clin Endocrinol Metab 106(4):e1827\u2013e1836. https:\/\/doi.org\/10.1210\/clinem\/dgaa751","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6519_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448\u2013453. https:\/\/doi.org\/10.1038\/nm.2307","journal-title":"Nat Med"},{"issue":"2","key":"6519_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639\u2013648. https:\/\/doi.org\/10.2337\/db12-0495","journal-title":"Diabetes"},{"issue":"2","key":"6519_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 169(2):361\u2013371. https:\/\/doi.org\/10.1016\/j.cell.2017.03.035","journal-title":"Cell"},{"key":"6519_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","volume":"45","author":"I Ben-Sahra","year":"2017","unstructured":"Ben-Sahra I, Manning BD (2017) mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol 45:72\u201382. https:\/\/doi.org\/10.1016\/j.ceb.2017.02.012","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"6519_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2020.03.035","volume":"98","author":"H Cao","year":"2020","unstructured":"Cao H, Luo J, Zhang Y et al (2020) Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis. Kidney Int 98(3):686\u2013698. https:\/\/doi.org\/10.1016\/j.kint.2020.03.035","journal-title":"Kidney Int"},{"issue":"6601","key":"6519_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1126\/science.abi9547","volume":"377","author":"AL Cangelosi","year":"2022","unstructured":"Cangelosi AL, Puszynska AM, Roberts JM et al (2022) Zonated leucine sensing by Sestrin-mTORC1 in the liver controls the response to dietary leucine. Science 377(6601):47\u201356. https:\/\/doi.org\/10.1126\/science.abi9547","journal-title":"Science"},{"issue":"2","key":"6519_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.kint.2017.01.021","volume":"92","author":"J Yamamoto","year":"2017","unstructured":"Yamamoto J, Nishio S, Hattanda F et al (2017) Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease. Kidney Int 92(2):377\u2013387. https:\/\/doi.org\/10.1016\/j.kint.2017.01.021","journal-title":"Kidney Int"},{"issue":"5","key":"6519_CR20","doi-asserted-by":"publisher","first-page":"114142","DOI":"10.1016\/j.celrep.2024.114142","volume":"43","author":"Z Yu","year":"2024","unstructured":"Yu Z, Li X, Quan Y et al (2024) Itaconate alleviates diet-induced obesity via activation of brown adipocyte thermogenesis. Cell Rep 43(5):114142. https:\/\/doi.org\/10.1016\/j.celrep.2024.114142","journal-title":"Cell Rep"},{"issue":"1","key":"6519_CR21","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-024-48914-w","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Du Y, Huang S et al (2024) Single-cell analysis reveals a subpopulation of adipose progenitor cells that impairs glucose homeostasis. Nat Commun 15(1):4827. https:\/\/doi.org\/10.1038\/s41467-024-48914-w","journal-title":"Nat Commun"},{"issue":"10","key":"6519_CR22","doi-asserted-by":"publisher","first-page":"e2305563","DOI":"10.1002\/advs.202305563","volume":"11","author":"H Wang","year":"2024","unstructured":"Wang H, Yu X, Liu D et al (2024) VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2\/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh) 11(10):e2305563. https:\/\/doi.org\/10.1002\/advs.202305563","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"6519_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.cmet.2022.09.008","volume":"34","author":"D Murashige","year":"2022","unstructured":"Murashige D, Jung JW, Neinast MD et al (2022) Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure. Cell Metab 34(11):1749-1764 e1747. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.008","journal-title":"Cell Metab"},{"issue":"1","key":"6519_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1042\/BJ20060869","volume":"400","author":"MA Joshi","year":"2006","unstructured":"Joshi MA, Jeoung NH, Obayashi M et al (2006) Impaired growth and neurological abnormalities in branched-chain alpha-keto acid dehydrogenase kinase-deficient mice. Biochem J 400(1):153\u2013162. https:\/\/doi.org\/10.1042\/BJ20060869","journal-title":"Biochem J"},{"issue":"11","key":"6519_CR25","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1007\/s00125-019-4948-4","volume":"62","author":"M Oshima","year":"2019","unstructured":"Oshima M, Jun M, Ohkuma T et al (2019) The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study. Diabetologia 62(11):1988\u20131997. https:\/\/doi.org\/10.1007\/s00125-019-4948-4","journal-title":"Diabetologia"},{"issue":"11","key":"6519_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","volume":"17","author":"M Oshima","year":"2021","unstructured":"Oshima M, Shimizu M, Yamanouchi M et al (2021) Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol 17(11):740\u2013750. https:\/\/doi.org\/10.1038\/s41581-021-00462-y","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"6519_CR27","doi-asserted-by":"publisher","first-page":"F476","DOI":"10.1152\/ajprenal.00363.2006","volume":"293","author":"S Terryn","year":"2007","unstructured":"Terryn S, Jouret F, Vandenabeele F et al (2007) A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am J Physiol Renal Physiol 293(2):F476-485. https:\/\/doi.org\/10.1152\/ajprenal.00363.2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"6519_CR28","doi-asserted-by":"publisher","first-page":"167060","DOI":"10.1016\/j.bbadis.2024.167060","volume":"1870","author":"R Shen","year":"2024","unstructured":"Shen R, Qin S, Lv Y et al (2024) GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis. Biochim Biophys Acta Mol Basis Dis 1870(4):167060. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167060","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"14","key":"6519_CR29","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1021\/acs.analchem.0c04686","volume":"93","author":"G Xie","year":"2021","unstructured":"Xie G, Wang L, Chen T et al (2021) A metabolite array technology for precision medicine. Anal Chem 93(14):5709\u20135717. https:\/\/doi.org\/10.1021\/acs.analchem.0c04686","journal-title":"Anal Chem"},{"key":"6519_CR30","doi-asserted-by":"publisher","first-page":"116076","DOI":"10.1016\/j.bcp.2024.116076","volume":"222","author":"Q Ke","year":"2024","unstructured":"Ke Q, Xiao Y, Liu D et al (2024) PPARalpha\/delta dual agonist H11 alleviates diabetic kidney injury by improving the metabolic disorders of tubular epithelial cells. Biochem Pharmacol 222:116076. https:\/\/doi.org\/10.1016\/j.bcp.2024.116076","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"6519_CR31","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/db10-1181","volume":"60","author":"KI Woroniecka","year":"2011","unstructured":"Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K (2011) Transcriptome analysis of human diabetic kidney disease. Diabetes 60(9):2354\u20132369. https:\/\/doi.org\/10.2337\/db10-1181","journal-title":"Diabetes"},{"issue":"2","key":"6519_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2337\/dc21-1415","volume":"45","author":"F Bragg","year":"2022","unstructured":"Bragg F, Kartsonaki C, Guo Y et al (2022) Circulating metabolites and the development of type 2 diabetes in chinese adults. Diabetes Care 45(2):477\u2013480. https:\/\/doi.org\/10.2337\/dc21-1415","journal-title":"Diabetes Care"},{"issue":"5","key":"6519_CR33","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/dom.15475","volume":"26","author":"JA de Klerk","year":"2024","unstructured":"de Klerk JA, Bijkerk R, Beulens JWJ et al (2024) Branched-chain amino acid levels are inversely associated with incident and prevalent chronic kidney disease in people with type 2 diabetes. Diabetes Obes Metab 26(5):1706\u20131713. https:\/\/doi.org\/10.1111\/dom.15475","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"6519_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.kint.2024.06.026","volume":"106","author":"A Ahmadi","year":"2024","unstructured":"Ahmadi A, Yu J, Loza JE et al (2024) Deceased donor kidney function and branched chain amino acid metabolism during ex vivo normothermic perfusion. Kidney Int 106(4):712\u2013722. https:\/\/doi.org\/10.1016\/j.kint.2024.06.026","journal-title":"Kidney Int"},{"issue":"12","key":"6519_CR35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-024-00872-8","volume":"20","author":"MGE Knol","year":"2024","unstructured":"Knol MGE, Wulfmeyer VC, Muller RU, Rinschen MM (2024) Amino acid metabolism in kidney health and disease. Nat Rev Nephrol 20(12):771\u2013788. https:\/\/doi.org\/10.1038\/s41581-024-00872-8","journal-title":"Nat Rev Nephrol"},{"issue":"24","key":"6519_CR36","doi-asserted-by":"publisher","first-page":"e183984","DOI":"10.1172\/JCI183984","volume":"134","author":"YJ Choi","year":"2024","unstructured":"Choi YJ, Richard G, Zhang G et al (2024) Attenuated kidney oxidative metabolism in young adults with type 1 diabetes. J Clin Invest 134(24):e183984. https:\/\/doi.org\/10.1172\/JCI183984","journal-title":"J Clin Invest"},{"issue":"5","key":"6519_CR37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cmet.2024.02.015","volume":"36","author":"H Li","year":"2024","unstructured":"Li H, Li D, Ledru N et al (2024) Transcriptomic, epigenomic, and spatial metabolomic cell profiling redefines regional human kidney anatomy. Cell Metab 36(5):1105\u20131125. https:\/\/doi.org\/10.1016\/j.cmet.2024.02.015","journal-title":"Cell Metab"},{"issue":"15","key":"6519_CR38","doi-asserted-by":"publisher","first-page":"e136845","DOI":"10.1172\/jci.insight.136845","volume":"5","author":"S Khan","year":"2020","unstructured":"Khan S, Gaivin R, Abramovich C, Boylan M, Calles J, Schelling JR (2020) Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression. JCI Insight 5(15):e136845. https:\/\/doi.org\/10.1172\/jci.insight.136845","journal-title":"JCI Insight"},{"issue":"11","key":"6519_CR39","doi-asserted-by":"publisher","first-page":"e168825","DOI":"10.1172\/jci.insight.168825","volume":"9","author":"M Darshi","year":"2024","unstructured":"Darshi M, Kugathasan L, Maity S et al (2024) Glycolytic lactate in diabetic kidney disease. JCI Insight 9(11):e168825. https:\/\/doi.org\/10.1172\/jci.insight.168825","journal-title":"JCI Insight"},{"issue":"5","key":"6519_CR40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41419-020-2544-7","volume":"11","author":"T Cai","year":"2020","unstructured":"Cai T, Ke Q, Fang Y et al (2020) Sodium-glucose cotransporter 2 inhibition suppresses HIF-1alpha-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice. Cell Death Dis 11(5):390. https:\/\/doi.org\/10.1038\/s41419-020-2544-7","journal-title":"Cell Death Dis"},{"issue":"6","key":"6519_CR41","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.kint.2024.01.044","volume":"105","author":"S Kume","year":"2024","unstructured":"Kume S, Packer M (2024) SGLT2 inhibitors act as metabolic transducers to restore healthy nutrient deprivation and surplus signaling in the kidney. Kidney Int 105(6):1172\u20131176. https:\/\/doi.org\/10.1016\/j.kint.2024.01.044","journal-title":"Kidney Int"},{"issue":"2","key":"6519_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141(2):290\u2013303. https:\/\/doi.org\/10.1016\/j.cell.2010.02.024","journal-title":"Cell"},{"issue":"3","key":"6519_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S Marchi","year":"2023","unstructured":"Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L (2023) Mitochondrial control of inflammation. Nat Rev Immunol 23(3):159\u2013173. https:\/\/doi.org\/10.1038\/s41577-022-00760-x","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6519_CR44","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1038\/s41467-021-25377-x","volume":"12","author":"Y Guan","year":"2021","unstructured":"Guan Y, Liang X, Ma Z et al (2021) A single genetic locus controls both expression of DPEP1\/CHMP1A and kidney disease development via ferroptosis. Nat Commun 12(1):5078. https:\/\/doi.org\/10.1038\/s41467-021-25377-x","journal-title":"Nat Commun"},{"issue":"7","key":"6519_CR45","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/d41573-021-00107-6","volume":"20","author":"MP East","year":"2021","unstructured":"East MP, Laitinen T, Asquith CRM (2021) BCKDK: an emerging kinase target for metabolic diseases and cancer. Nat Rev Drug Discov 20(7):498. https:\/\/doi.org\/10.1038\/d41573-021-00107-6","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"6519_CR46","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41591-018-0194-4","volume":"24","author":"C Qiu","year":"2018","unstructured":"Qiu C, Huang S, Park J et al (2018) Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med 24(11):1721\u20131731. https:\/\/doi.org\/10.1038\/s41591-018-0194-4","journal-title":"Nat Med"},{"issue":"6","key":"6519_CR47","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI111619","volume":"74","author":"RC Harris","year":"1984","unstructured":"Harris RC, Seifter JL, Brenner BM (1984) Adaptation of Na+-H+ exchange in renal microvillus membrane vesicles. Role of dietary protein and uninephrectomy. J Clin Invest 74(6):1979\u20131987. https:\/\/doi.org\/10.1172\/JCI111619","journal-title":"J Clin Invest"},{"issue":"5","key":"6519_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1681\/ASN.2021060751","volume":"33","author":"KA Lidberg","year":"2022","unstructured":"Lidberg KA, Muthusamy S, Adil M et al (2022) Serum protein exposure activates a core regulatory program driving human proximal tubule injury. J Am Soc Nephrol 33(5):949\u2013965. https:\/\/doi.org\/10.1681\/ASN.2021060751","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"6519_CR49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ki.2012.20","volume":"82","author":"I Grgic","year":"2012","unstructured":"Grgic I, Campanholle G, Bijol V et al (2012) Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82(2):172\u2013183. https:\/\/doi.org\/10.1038\/ki.2012.20","journal-title":"Kidney Int"},{"issue":"3","key":"6519_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41581-024-00907-0","volume":"21","author":"AB Fogo","year":"2024","unstructured":"Fogo AB, Harris RC (2024) Crosstalk between glomeruli and tubules. Nat Rev Nephrol 21(3):189\u2013199. https:\/\/doi.org\/10.1038\/s41581-024-00907-0","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"6519_CR51","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI44774","volume":"121","author":"M Godel","year":"2011","unstructured":"Godel M, Hartleben B, Herbach N et al (2011) Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 121(6):2197\u20132209. https:\/\/doi.org\/10.1172\/JCI44774","journal-title":"J Clin Invest"},{"issue":"3","key":"6519_CR52","doi-asserted-by":"publisher","first-page":"105702","DOI":"10.1016\/j.jbc.2024.105702","volume":"300","author":"A Acevedo","year":"2024","unstructured":"Acevedo A, Jones AE, Danna BT et al (2024) The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis. J Biol Chem 300(3):105702. https:\/\/doi.org\/10.1016\/j.jbc.2024.105702","journal-title":"J Biol Chem"},{"issue":"3","key":"6519_CR53","doi-asserted-by":"publisher","first-page":"102959","DOI":"10.1016\/j.jbc.2023.102959","volume":"299","author":"S Liu","year":"2023","unstructured":"Liu S, Kormos BL, Knafels JD et al (2023) Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors. J Biol Chem 299(3):102959. https:\/\/doi.org\/10.1016\/j.jbc.2023.102959","journal-title":"J Biol Chem"},{"issue":"6","key":"6519_CR54","doi-asserted-by":"publisher","first-page":"112641","DOI":"10.1016\/j.celrep.2023.112641","volume":"42","author":"K Nishi","year":"2023","unstructured":"Nishi K, Yoshii A, Abell L et al (2023) Branched-chain keto acids inhibit mitochondrial pyruvate carrier and suppress gluconeogenesis in hepatocytes. Cell Rep 42(6):112641. https:\/\/doi.org\/10.1016\/j.celrep.2023.112641","journal-title":"Cell Rep"},{"issue":"3","key":"6519_CR55","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","volume":"297","author":"L Hue","year":"2009","unstructured":"Hue L, Taegtmeyer H (2009) The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297(3):E578-591. https:\/\/doi.org\/10.1152\/ajpendo.00093.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"6519_CR56","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.kint.2025.04.025","volume":"108","author":"E Bollinger","year":"2025","unstructured":"Bollinger E, Williams G, Piper ME et al (2025) Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models. Kidney Int 108(2):310\u2013316. https:\/\/doi.org\/10.1016\/j.kint.2025.04.025","journal-title":"Kidney Int"},{"issue":"7","key":"6519_CR57","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2337\/db09-1744","volume":"59","author":"A Mollsten","year":"2010","unstructured":"Mollsten A, Svensson M, Waernbaum I et al (2010) Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes 59(7):1803\u20131808. https:\/\/doi.org\/10.2337\/db09-1744","journal-title":"Diabetes"},{"issue":"7083","key":"6519_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/bmj.314.7083.783","volume":"314","author":"MA Gall","year":"1997","unstructured":"Gall MA, Hougaard P, Borch-Johnsen K, Parving HH (1997) Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ 314(7083):783\u2013788. https:\/\/doi.org\/10.1136\/bmj.314.7083.783","journal-title":"BMJ"},{"issue":"737","key":"6519_CR59","doi-asserted-by":"publisher","first-page":"eabm2090","DOI":"10.1126\/scitranslmed.abm2090","volume":"16","author":"S Clotet-Freixas","year":"2024","unstructured":"Clotet-Freixas S, Zaslaver O, Kotlyar M et al (2024) Sex differences in kidney metabolism may reflect sex-dependent outcomes in human diabetic kidney disease. Sci Transl Med 16(737):eabm2090. https:\/\/doi.org\/10.1126\/scitranslmed.abm2090","journal-title":"Sci Transl Med"},{"issue":"4","key":"6519_CR60","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.jdiacomp.2020.107841","volume":"35","author":"F Piani","year":"2021","unstructured":"Piani F, Melena I, Tommerdahl KL et al (2021) Sex-related differences in diabetic kidney disease: a review on the mechanisms and potential therapeutic implications. J Diabetes Complications 35(4):107841. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107841","journal-title":"J Diabetes Complications"},{"issue":"2","key":"6519_CR61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2215\/CJN.0000000642","volume":"20","author":"SA van Eeghen","year":"2024","unstructured":"van Eeghen SA, Nokoff NJ, Vosters TG et al (2024) Unraveling sex differences in kidney health and CKD: a review of the effect of sex hormones. Clin J Am Soc Nephrol 20(2):301\u2013310. https:\/\/doi.org\/10.2215\/CJN.0000000642","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"6519_CR62","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1038\/s41467-022-32972-z","volume":"13","author":"PC Wilson","year":"2022","unstructured":"Wilson PC, Muto Y, Wu H, Karihaloo A, Waikar SS, Humphreys BD (2022) Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression. Nat Commun 13(1):5253. https:\/\/doi.org\/10.1038\/s41467-022-32972-z","journal-title":"Nat Commun"},{"issue":"11","key":"6519_CR63","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.2337\/db20-0382","volume":"69","author":"A Bansal","year":"2020","unstructured":"Bansal A, Balasubramanian S, Dhawan S, Leung A, Chen Z, Natarajan R (2020) Integrative omics analyses reveal epigenetic memory in diabetic renal cells regulating genes associated with kidney dysfunction. Diabetes 69(11):2490\u20132502. https:\/\/doi.org\/10.2337\/db20-0382","journal-title":"Diabetes"},{"issue":"2","key":"6519_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"The E-KCG, Herrington WG, Staplin N et al (2023) Empagliflozin in patients with chronic kidney disease. N Engl J Med 388(2):117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa2204233","journal-title":"N Engl J Med"},{"issue":"2","key":"6519_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P et al (2024) Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med 391(2):109\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa2403347","journal-title":"N Engl J Med"},{"issue":"23","key":"6519_CR66","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD et al (2020) Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 383(23):2219\u20132229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"issue":"4S","key":"6519_CR67","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes CKDWG","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes CKDWG (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"issue":"11","key":"6519_CR68","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00125-023-05985-6","volume":"66","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhang X, Pei J, Liu Y, Niu W, Sun H (2023) Targeting BCAA metabolism to potentiate metformin\u2019s therapeutic efficacy in the treatment of diabetes in mice. Diabetologia 66(11):2139\u20132153. https:\/\/doi.org\/10.1007\/s00125-023-05985-6","journal-title":"Diabetologia"},{"issue":"1","key":"6519_CR69","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1038\/s41467-022-31249-9","volume":"13","author":"F Vanweert","year":"2022","unstructured":"Vanweert F, Neinast M, Tapia EE et al (2022) A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes. Nat Commun 13(1):3508. https:\/\/doi.org\/10.1038\/s41467-022-31249-9","journal-title":"Nat Commun"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06519-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06519-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:02:18Z","timestamp":1786838538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06519-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6519"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06519-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors thank the investigators, staff and participants and their families for dedication and commitment to the trial. The authors acknowledge the public platform of the State Key Laboratory of Natural Medicines of China Pharmaceutical University for the use of Seahorse Bioscience XF pro extracellular flux analyser in the OCR and ECAR experiments. We also appreciate W. Jiang of the China Pharmaceutical University for his technical support in the OCR and ECAR experiments. Part of this work was presented as an abstract at the 2024 annual meeting of the American Society of Nephrology.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The transcriptomic data supporting the findings of this study are openly available at the National Center for Biotechnology Information Sequence ReadArchive (SRA) (\n                      \n                      , identifiers: PRJNA1180888 and PRJNA1180923). The metabolomics data associated with the manuscript are available in the\n                      \n                      .","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study is supported by the National Natural Science Foundation of China: General program 82270760, Natural Science Foundation of Jiangsu province: General program BK20201497 and National Natural Science Foundation of China: Youth fund 82200802 and by a Joint Technology Enhancement Project between the Second Affiliated Hospital of Nanjing Medical University and Binhai County People\u2019s Hospital EFYBH01C.","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"YZ, CD, KZ and LJ designed the study. YZ, CD, LJ, CS and QK acquired funding for the study. CS, XWa, SQ, AH, XWu, QK, RS, YW, LW, YX, DL, XY, XS, YS and XZ acquired or generated the data. YZ, CD, KZ, LJ, CS, XWa, AH and XWu analysed the data. YZ wrote the manuscript. YZ, CD, KZ, LJ, AH and XWu provided scientific guidance and insights. All authors reviewed, edited and approved the manuscript. YZ, CD, KZ and LJ are the guarantors of this work.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}